RCRP051
Human iPS Cells established from fibroblasts, reprogrammed with REPROCELL's StemRNA Reprogramming technology, with knockout in the CIITA (HLA Class II) genes.
RCRP052
Human iPSCs established from fibroblasts, reprogrammed with REPROCELL's Clinical StemRNA Reprogramming technology, with double knockout in the B2M (HLA Class I) and CIITA (HLA Class II) genes.
RCRP053
Human iPSCs established from fibroblasts, reprogrammed with REPROCELL's Clinical StemRNA Reprogramming technology, with a knockout of both alleles of the B2M (HLA Class I) gene.
03-0020
StemEdit OC-1 Protein is a recombinant, AI-designed genome editing nuclease developed as a next-generation alternative to conventional Cas nucleases. It combines high editing efficiency with low off-target activity while enabling license-free genome engineering research, helping researchers simplify project planning and reduce intellectual property barriers.
